Adage Capital Partners’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Adage Capital Partners’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-85,000	Closed	-$5.5M	–	703
2016 Q3	$5.5M	Sell	85,000 -150,000	-64%	-$8.45M	0.02%	606
2016 Q2	$13M	Buy	235,000 +85,000	+57%	+$4.27M	0.04%	462
2016 Q1	$6.27M	Sell	150,000 -150,000	-50%	-$6.96M	0.02%	584
2015 Q4	$18.9M	Sell	300,000 -226,460	-43%	-$11.6M	0.05%	384
2015 Q3	$21.4M	Buy	526,460 +301,460	+134%	+$17.4M	0.06%	364
2015 Q2	$11.6M	Buy	+225,000	New	+$11.9M	0.03%	524

Other funds holding LKFT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Adage Capital Partners's LKFT Position: Q4 2016 in Review

Adage Capital Partners sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2016, closing a stake of 85,000 shares — an estimated $5.5M sold.

Adage Capital Partners first reported a position in LKFT in Q2 2015 and held it in 6 quarters. The position peaked at $21.4M in Q3 2015. 52 funds tracked by Wall St. Rank hold LKFT as of Q4 2016.

Adage Capital Partners reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2016 after selling out during the quarter.
Adage Capital Partners sold 85,000 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2016, an estimated $5.5M.
Adage Capital Partners first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2015 and held it in 6 quarters.
Adage Capital Partners's Lakefront Biotherapeutics American Depositary Shares position peaked at $21.4M in Q3 2015.
52 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2016.

Based on Adage Capital Partners's 13F filing for Q4 2016, filed 14 Feb 2017.